[go: up one dir, main page]

MX2013013098A - Metodos y composiciones para fomentar el crecimiento de la masa corporal magra. - Google Patents

Metodos y composiciones para fomentar el crecimiento de la masa corporal magra.

Info

Publication number
MX2013013098A
MX2013013098A MX2013013098A MX2013013098A MX2013013098A MX 2013013098 A MX2013013098 A MX 2013013098A MX 2013013098 A MX2013013098 A MX 2013013098A MX 2013013098 A MX2013013098 A MX 2013013098A MX 2013013098 A MX2013013098 A MX 2013013098A
Authority
MX
Mexico
Prior art keywords
methods
body mass
compositions
lean body
mass growth
Prior art date
Application number
MX2013013098A
Other languages
English (en)
Inventor
Yuanlong Pan
George Wells
Delphine Tissot-Favre
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013013098A publication Critical patent/MX2013013098A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención proporciona métodos para fomentar el crecimiento de la masa corporal magra en un animal. Los métodos comprenden administrarles OEA a los animales, preferiblemente en cantidades de desde aproximadamente 0.01 a aproximadamente 1000 mg/kg/día.
MX2013013098A 2011-05-10 2012-05-08 Metodos y composiciones para fomentar el crecimiento de la masa corporal magra. MX2013013098A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161518704P 2011-05-10 2011-05-10
PCT/US2012/036874 WO2012154711A1 (en) 2011-05-10 2012-05-08 Methods and compositions for promoting lean body mass growth

Publications (1)

Publication Number Publication Date
MX2013013098A true MX2013013098A (es) 2013-12-16

Family

ID=47139586

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013013098A MX2013013098A (es) 2011-05-10 2012-05-08 Metodos y composiciones para fomentar el crecimiento de la masa corporal magra.

Country Status (11)

Country Link
US (1) US20140193370A1 (es)
EP (1) EP2706849A4 (es)
JP (1) JP2014519494A (es)
CN (1) CN103596429A (es)
AU (1) AU2012253697A1 (es)
BR (1) BR112013028723A2 (es)
CA (1) CA2835429A1 (es)
MX (1) MX2013013098A (es)
RU (1) RU2013154564A (es)
WO (1) WO2012154711A1 (es)
ZA (1) ZA201309260B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104602536A (zh) * 2012-09-07 2015-05-06 雀巢产品技术援助有限公司 油酰乙醇胺组合物
US10016382B2 (en) 2014-06-12 2018-07-10 Lonza Inc. Method for decreasing skeletal muscle damage and/or oxidative stress in mammals
JP2018537987A (ja) 2015-12-18 2018-12-27 ロンザ インコーポレイテッド 哺乳動物において筋タンパク質合成および／または機能強度を増大させる方法および組成物ならびに組成物を製造する方法
US10702487B2 (en) 2017-08-19 2020-07-07 Frimline Private Limited Pharmaceutical composition for prevention of diet induced obesity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338329B2 (en) * 2001-03-27 2006-09-07 The Regents Of The University Of California Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
WO2004045307A2 (en) * 2002-11-18 2004-06-03 Natural Asa Dietry supplements and foods product comprising oleylethanolamide
US20050031549A1 (en) * 2003-06-09 2005-02-10 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
WO2005046580A2 (en) * 2003-10-16 2005-05-26 The Regents Of The University Of California Dietary and other compositions, compounds, and methods for reducing body fat, controlling appetite, and modulating fatty acid metabolism
JP5931337B2 (ja) * 2007-10-04 2016-06-08 ネステク ソシエテ アノニム 認知機能を高める組成物及び方法
CN102791145A (zh) * 2010-03-24 2012-11-21 雀巢产品技术援助有限公司 增强可食用组合物的适口性的方法

Also Published As

Publication number Publication date
BR112013028723A2 (pt) 2016-08-09
US20140193370A1 (en) 2014-07-10
AU2012253697A1 (en) 2013-11-21
EP2706849A1 (en) 2014-03-19
JP2014519494A (ja) 2014-08-14
EP2706849A4 (en) 2014-11-12
WO2012154711A1 (en) 2012-11-15
RU2013154564A (ru) 2015-06-20
CN103596429A (zh) 2014-02-19
ZA201309260B (en) 2015-10-28
CA2835429A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
PH12013501136A1 (en) Lysophosphatidic acid receptor antagonists and uses thereof
MX2019009654A (es) Anticuerpos e inmunoconjugados del receptor 1 de folato y usos de los mismos.
IN2012DN02177A (es)
IN2012DN02702A (es)
IN2012DN00754A (es)
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
MY163055A (en) Polycyclic antagonists of lysophosphatidic acid receptors
IN2012DN06720A (es)
WO2012149412A3 (en) Anti-endoglin (cd105) antibodies, immunoconjugates, and uses thereof
MX2013004061A (es) Analogos de ciclosporina.
MX342257B (es) Derivados y análogos de oxaspiro [2.5] octano.
MX360774B (es) Antagonistas de progesterona.
MX2013011996A (es) Metodos para regular la expresion de genes de sirtuina.
AU2016216741A1 (en) Compositions and methods of use of an inappetance-controlling compound
IN2014CN04773A (es)
MX2013004062A (es) Analogos de ciclosporina.
MX2012013478A (es) Composicion para evitar perdida del cabello o estimular crecimiento del cabello.
PH12013500371A1 (en) Therapeutic agent for pain
MX2013013098A (es) Metodos y composiciones para fomentar el crecimiento de la masa corporal magra.
MX2013007191A (es) Metodos y composiciones para prevenir y tratar la osteoartritis.
MX2013006353A (es) Metodos y composiciones utiles para promover el sueño en animales.
MX2017006638A (es) Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso.
MX2013012990A (es) Metodos y composiciones para preservar la masa corporal magra durante la perdida de peso.
MX360787B (es) Metodos para reducir neurodegeneracion.
MX2013002446A (es) Derivados de tetrahidropirrolopirazina sustituidos.